Crotoxin is responsible for the long-lasting anti-inflammatory effect of Crotalus durissus terrificus snake venom: involvement of formyl peptide receptors

Toxicon

Volumn 55, Issue 6, 2010, Pages 1100-1106

  Nunes, F P B ^a   Zychar, B C ^a   Della Casa, M S ^a   Sampaio, S C ^a   Goncalves L R C ^a   Cirillo, M C ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Carrageenan; Cell migration; Crotoxin; Inflammation; Microcirculation; Paw edema

Indexed keywords

CARRAGEENAN; CROTOXIN; FORMYLPEPTIDE RECEPTOR; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CROTALUS DURISSUS; DRUG EFFICACY; ENDOTHELIUM CELL; ENZYME ACTIVATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PURIFICATION; SNAKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CELL MOVEMENT; CROTALUS; CROTOXIN; DISEASE MODELS, ANIMAL; EDEMA; ENDOTHELIUM, VASCULAR; HINDLIMB; INFLAMMATION; LEUKOCYTES; MALE; MICE; MICROCIRCULATION; MUSCLE, SKELETAL; PERITONEUM; RECEPTORS, FORMYL PEPTIDE;

ANIMALIA; CHINO DEL TOMATE VIRUS; CROTALUS DURISSUS TERRIFICUS; MUS;

EID: 77649275944     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.12.011     Document Type: Article

References (36)

1. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc. Res. 5 3 (1973) 384-394
2. Bannenberg G.L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K.H., Hong S., and Serhan C.N. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174 7 (2005) 4345-4355
3. Cardoso D.F., Lopes-Ferreira M., Faquim-Mauro E.L., Macedo M.S., and Farsky S.H. Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions. Mediat. Inflamm. 10 3 (2001) 125-133
4. Chiang N., and Serhan C.N. New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications. Compr. Ther. 32 3 (2006) 150-157
5. Cuzzocrea S., Sautebin L., De Sarro G., Constantino G., Rombola L., Mazzon E., Ialenti A., Ciliberto G., Di Rosa M., Caputi A.P., and Thiemermann C. Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J. Immunol. 163 9 (1999) 5094-5104
6. Cuzzocrea S., Rossi A., Serraino I., Mazzon E., Di Paolo R., Dugo L., Genovese T., Calabrò B., Caputi A.P., and Sautebin L. 5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan. J. Leukoc. Biol. 73 6 (2003) 739-746
7. Diamond P., McGinty A., Sugrue D., Brady H.R., and Godson C. Regulation of leukocyte trafficking by lipoxins. Clin. Chem. Lab. Med. 37 3 (1999) 293-297
8. Dinarello C.A., Koch K.M., and Shaldon S. Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Int. Suppl. 24 (1988) S21-S26
9. Fiore S., and Serhan C.N. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloids cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 34 51 (1995) 16678-16686
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
11. 2. Br. J. Pharmacol. 114 3 (1995) 578-583
12. Levy L. Carrageenan paw oedema in the mouse. Life Sci. 8 (1969) 601-606
13. Ley K., Laudanna C., Cybulsky M.I., and Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 9 (2007) 678-689
14. 2 activity by a colorimetric assay using a pH indicator. Toxicon 25 11 (1987) 1181-1188
15. Machado F.S., Johndrow J.E., Esper L., Dias A., Bafica A., Serhan C.N., and Aliberti J. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 12 3 (2006) 330-334
16. Malech H.L., and Gallin J.I. Currents concepts: immunology. Neutrophils in human diseases. N. Engl. J. Med. 317 11 (1987) 687-694
17. Menezes-de-Lima Jr. O., Kassuya C.A., Nascimento A.F., Henriques M.G., and Calixto J.B. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. Prostaglandins Other Lipid Mediat. 80 3-4 (2006) 123-135
18. Nunes F.P.B., Sampaio S.C., Santoro M.L., and Sousa-e-Silva M.C.C. Long-lasting anti-inflammatory properties of Crotalus durissus terrificus snake venom in mice. Toxicon 49 (2007) 1090-1098
19. Rangel-Santos A., Dos-Santos E.C., Lopes-Ferreira M., Lima C., Cardoso D.F., and Mota I. A comparative study of biological activities of crotoxin and CB fraction of venoms from Crotalus durissus terrificus, Crotalus durissus cascavella and Crotalus durissus collilineatus. Toxicon 43 7 (2004) 801-810
20. Rankin J.A. Biological mediators of acute inflammation. AACN Clin. Iss. 15 1 (2004) 3-17
21. Rosenfeld G. Método rápido de coloração de esfregaços de sangue: noções práticas sobre corantes pancrômicos e estudos de diversos fatores. Mem. Inst. Butantan 20 (1947) 315-328
22. Rosenfeld G. Syntomatology, pathology and treatment of snake bites in South America. In: Bücherl W., and Buckley E. (Eds). Venomous Animals and Their Venoms vol. 2 (1971), Academic Press, New York 345-384
23. Sampaio S.C., Sousa-e-Silva M.C.C., Borelli P., Curi R., and Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J. Leukoc. Biol. 70 4 (2001) 551-558
24. Sampaio S.C., Brigatte P., Sousa-e-Silva M.C., Dos-Santos E.C., Rangel-Santos A.C., Curi R., and Cury Y. Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. Toxicon 41 7 (2003) 899-907
25. Sampaio S.C., Alba-Loureiro T.C., Brigatte P., Landgraf R.G.C., dos Santos E.C., Curi R., and Cury Y. Lipoxygenase-derived eicosanoids are involved in the inhibitory effect of Crotalus durissus terrificus venom or crotoxin on rat macrophage phagocytosis. Toxicon 47 3 (2006) 313-321
26. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25 (2007) 101-137
27. Slotta K.H., and Fraenkel-Conrat H. Estudos químicos sobre os venenos ofídicos. Purificação e cristalização do veneno da cobra cascavel. Mem. Inst. Butantan 12 (1938) 505
28. Sousa-e-Silva M.C.C., Gonçalves L.R.C., and Mariano M. The venom of South American ratllesnake inhibits macrophage functions and is endowed with anti-inflammatory properties. Mediat. Inflamm. 5 1 (1996) 18-23
29. 4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49 3 (1994) 230-234
30. Stenfeldt A.L., Karlsson J., Wennerås C., Bylund J., Fu H., and Dahlgren C. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30 6 (2007) 224-229
31. Takemura R., and Werb Z. Secretory products of macrophages and their physiological functions. Am. J. Physiol. 246 1 Pt 1 (1984) C1-C9
32. Utsunomyia I., Nagai S., and Oh-Ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J. Immunol. 147 6 (1991) 1803-1809
33. Walzog B., and Gaehtgens P. Adhesion molecules: the path to a new understanding of acute inflammation. News Physiol. Sci. 15 (2000) 107-113
34. Whitman S., Gezginci M., Timmermann B.N., and Holman T.R. Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward Soybean, 12-human, and 15-human lipoxygenase. J. Med. Chem. 45 12 (2002) 2659-2661
35. Yadav R., Larbi K.Y., Young R.E., and Nourshargh S. Migration of leukocytes through the vessel wall and beyond. Thromb. Haemost. 90 4 (2003) 598-606
36. Ye R.D., Boulay F., Wang J.M., Dahlgren C., Gerard C., Parmentier M., Serhan C.N., and Murphy P.M. International union of basic and clinical pharmacology. LXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 61 2 (2009) 119-161